Form 8-K · Biotech and pharma

Recent 8-K filings: Biotech and pharma

470 8-K filings from 305 companies in Biotech and pharma in the last 30 days, newest first, each with a one-line summary.

Latest 8-Ks

Oct 16, 2026 NRXPW NRX Pharmaceuticals, Inc.
NRXP sets 2026 Annual Meeting date
8-K on SEC.gov
Oct 16, 2026 ADIL ADIAL PHARMACEUTICALS, INC.
ADIAL PHARMACEUTICALS adjourns meeting
8-K on SEC.gov
Oct 16, 2026 Iambic Therapeutics, Inc.
Iambic Therapeutics files IPO amendments
8-K on SEC.gov
Oct 16, 2026 CGC Canopy Growth Corp
Canopy Growth fails Nasdaq listing rule
8-K on SEC.gov
Oct 16, 2026 PMCB PharmaCyte Biotech, Inc.
PharmaCyte Biotech fires auditor
8-K on SEC.gov
Oct 16, 2026 HURA TuHURA Biosciences, Inc./NV
TuHURA Biosciences borrows $650K
8-K on SEC.gov
Oct 16, 2026 MDCXW Medicus Pharma Ltd.
Medicus Pharma Ltd. consolidates shares.
8-K on SEC.gov
Oct 16, 2026 CALC CalciMedica, Inc.
CalciMedica CFO steps down
8-K on SEC.gov
Oct 16, 2026 ALEC Alector, Inc.
Alector, Inc. announces stock offering
8-K on SEC.gov
Oct 16, 2026 TCRX TScan Therapeutics, Inc.
TScan Therapeutics reports director departures
8-K on SEC.gov
Oct 16, 2026 ACXP Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals holds annual meeting
8-K on SEC.gov
Oct 16, 2026 OCUL OCULAR THERAPEUTIX, INC
OCULAR THERAPEUTIX, INC. loses Chief Strategy Officer
8-K on SEC.gov
Oct 16, 2026 MYNZ Quantum Cyber N.V.
Quantum Cyber N.V. appoints new director
8-K on SEC.gov
Oct 16, 2026 AIBT AIBOTICS, INC.
AIBOTICS acquires PlayJamaica assets
8-K on SEC.gov
Oct 16, 2026 VIVS VivoSim Labs, INC.
VivoSim Labs reduces office space
8-K on SEC.gov
Oct 16, 2026 MAZE Maze Therapeutics, Inc.
Maze Therapeutics exchanges stock for warrants
8-K on SEC.gov
Oct 16, 2026 ATYR aTYR PHARMA INC
aTyr Pharma approves stock split proposal
8-K on SEC.gov
Oct 16, 2026 CSBR CHAMPIONS ONCOLOGY, INC.
Champions Oncology holds annual meeting
8-K on SEC.gov
Oct 16, 2026 MBRX Moleculin Biotech, Inc.
Moleculin Biotech files 8-K on 2026-10-16
8-K on SEC.gov
Oct 16, 2026 ERAS Erasca, Inc.
Erasca fires COO Nik Chetwyn
8-K on SEC.gov
Oct 16, 2026 EBS Emergent BioSolutions Inc.
EBS names new CFO as Lindahl retires
8-K on SEC.gov
Oct 16, 2026 IRWD IRONWOOD PHARMACEUTICALS INC
Ironwood Pharmaceuticals appoints new CEO
8-K on SEC.gov
Oct 16, 2026 RGNX REGENXBIO Inc.
REGENXBIO Inc. announces board changes
8-K on SEC.gov
Oct 15, 2026 ERNAW Ernexa Therapeutics Inc.
Ernexa Therapeutics releases investor presentation
8-K on SEC.gov
Oct 15, 2026 IRD Opus Genetics, Inc.
Opus Genetics reports conference presentations
8-K on SEC.gov
Oct 15, 2026 BHVN Biohaven Ltd.
Biohaven Ltd. signs $80M licensing deal with Ono.
8-K on SEC.gov
Oct 15, 2026 ATNM Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals appoints new CFO
8-K on SEC.gov
Oct 15, 2026 BMRA BIOMERICA INC
BIOMERICA INC reports director departure
8-K on SEC.gov
Oct 15, 2026 OLMA Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals reports director changes
8-K on SEC.gov
Oct 15, 2026 ALXO ALX ONCOLOGY HOLDINGS INC
ALXO exchanges shares for warrants
8-K on SEC.gov
Oct 15, 2026 NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
NTHI appoints new director
8-K on SEC.gov
Oct 15, 2026 TRAXV First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics raises $200M
8-K on SEC.gov
Oct 15, 2026 CBIO CRESCENT BIOPHARMA, INC.
Crescent Biopharma announces clinical updates.
8-K on SEC.gov
Oct 15, 2026 AVXL ANAVEX LIFE SCIENCES CORP.
Anavex receives FDA go-ahead for clinical study
8-K on SEC.gov
Oct 15, 2026 INDV Indivior Pharmaceuticals, Inc.
Indivior approves share issuance proposal
8-K on SEC.gov
Oct 15, 2026 IBACR IB Acquisition Corp.
IBAC sets 2026 annual meeting on Dec 16
8-K on SEC.gov
Oct 15, 2026 SUPN SUPERNUS PHARMACEUTICALS, INC.
Supernus Pharmaceuticals merges with Indivior
8-K on SEC.gov
Oct 15, 2026 OPK OPKO HEALTH, INC.
OPKO sells pathology business for $722M
8-K on SEC.gov
Oct 15, 2026 MBIO MUSTANG BIO, INC.
Mustang Bio, Inc. granted extension to fix stock price
8-K on SEC.gov
Oct 15, 2026 ADTX Aditxt, Inc.
Aditxt terminates deal with Copley
8-K on SEC.gov
Oct 15, 2026 EVFM Evofem Biosciences, Inc.
Evofem Biosciences amends agreement
8-K on SEC.gov
Oct 15, 2026 SNTI Senti Biosciences Holdings, Inc.
SNTI holds 2026 Annual Meeting
8-K on SEC.gov
Oct 15, 2026 ABBV AbbVie Inc.
AbbVie expands board with new director
8-K on SEC.gov
Oct 15, 2026 CRBP Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals updates investor presentation.
8-K on SEC.gov
Oct 15, 2026 BIAFW bioAffinity Technologies, Inc.
BIAF announces CHEST 2026 presentation
8-K on SEC.gov
Oct 15, 2026 EDSA Edesa Biotech, Inc.
Edesa Biotech gets FDA clearance for EB06 trial
8-K on SEC.gov
Oct 15, 2026 RXRX RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals raises $200M
8-K on SEC.gov
Oct 15, 2026 OCGN Ocugen, Inc.
Ocugen files 8-K with new presentation
8-K on SEC.gov
Oct 15, 2026 TIVC Valion Bio, Inc.
Valion Bio announces BioScan-NMR evaluation
8-K on SEC.gov
Oct 15, 2026 JSPRW Jasper Therapeutics, Inc.
Jasper Therapeutics completes IgAN cohort enrollment
8-K on SEC.gov
Oct 15, 2026 AQST Aquestive Therapeutics, Inc.
Aquestive Therapeutics announces FDA accepted NDA resubmission
8-K on SEC.gov
Oct 15, 2026 KRYS Krystal Biotech, Inc.
Krystal Biotech shares clinical data on KB113
8-K on SEC.gov
Oct 15, 2026 CRON Cronos Group Inc.
Cronos completes CanAdelaar acquisition
8-K on SEC.gov
Oct 15, 2026 TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals reports Q3 2026 revenue estimates
8-K on SEC.gov
Oct 15, 2026 OCGN Ocugen, Inc.
Ocugen signs $255M deal with Roots
8-K on SEC.gov
Oct 14, 2026 VSTM Verastem, Inc.
Verastem raises $234.7M via stock and warrants
8-K on SEC.gov
Oct 14, 2026 IBRX ImmunityBio, Inc.
ImmunityBio expands ANKTIVA approval
8-K on SEC.gov
Oct 14, 2026 MTEX MANNATECH INC
MANNATECH INC regained Nasdaq compliance
8-K on SEC.gov
Oct 14, 2026 RZLT Rezolute, Inc.
Rezolute completes upLIFT study enrollment
8-K on SEC.gov
Oct 14, 2026 ELVN Enliven Therapeutics, Inc.
Enliven appoints Kristine Ball to board
8-K on SEC.gov
Oct 14, 2026 LNTH Lantheus Holdings, Inc.
Lantheus approves merger agreement
8-K on SEC.gov
Oct 14, 2026 SILO Silo Pharma, Inc.
Silo Pharma acquires software assets
8-K on SEC.gov
Oct 14, 2026 LSTA LISATA THERAPEUTICS, INC.
Lisata Therapeutics adds Jeff Farrow to board
8-K on SEC.gov
Oct 14, 2026 CRVO CervoMed Inc.
CervoMed Inc. files 8-K
8-K on SEC.gov
Oct 14, 2026 SBFMW Sunshine Biopharma Inc.
Sunshine Biopharma approves stock issuance
8-K on SEC.gov
Oct 14, 2026 LGVN Longeveron Inc.
Longeveron Inc. announces CMO departure
8-K on SEC.gov
Oct 14, 2026 ONCY ONCOLYTICS BIOTECH INC
Oncolytics Biotech announces GOBLET study updates
8-K on SEC.gov
Oct 14, 2026 RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx sells PRV for $203M
8-K on SEC.gov
Oct 14, 2026 ALEC Alector, Inc.
Alector, Inc. reprices stock options
8-K on SEC.gov
Oct 14, 2026 APVO Aptevo Therapeutics Inc.
Aptevo announces platform presentation at SITC 2026
8-K on SEC.gov
Oct 14, 2026 VIR Vir Biotechnology, Inc.
Vir Biotechnology partners with Gilead
8-K on SEC.gov
Oct 14, 2026 COYA Coya Therapeutics, Inc.
Coya Therapeutics initiates OLE trial
8-K on SEC.gov
Oct 14, 2026 TIVC Valion Bio, Inc.
Valion Bio, Inc. announces Velocity Bioworks expansion.
8-K on SEC.gov
Oct 14, 2026 MXCT MAXCYTE, INC.
MaxCyte raises 2026 revenue guidance.
8-K on SEC.gov
Oct 14, 2026 ONMDW OneMedNet Corp
OneMedNet regains Nasdaq compliance
8-K on SEC.gov
Oct 14, 2026 AKBA Akebia Therapeutics, Inc.
Akebia Therapeutics CEO resigns
8-K on SEC.gov
Oct 14, 2026 TRDA Entrada Therapeutics, Inc.
Entrada Therapeutics reports positive Cohort 1 results
8-K on SEC.gov
Oct 14, 2026 KPTI Karyopharm Therapeutics Inc.
Karyopharm extends forbearance period
8-K on SEC.gov
Oct 14, 2026 AQST Aquestive Therapeutics, Inc.
Aquestive licenses LIBERVANT to Eton
8-K on SEC.gov
Oct 14, 2026 ETON Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals acquires LIBERVANT license
8-K on SEC.gov
Oct 14, 2026 XERS Xeris Biopharma Holdings, Inc.
Xeris Biopharma files patent lawsuits
8-K on SEC.gov
Oct 14, 2026 UTHR UNITED THERAPEUTICS Corp
United Therapeutics settles litigation with Liquidia
8-K on SEC.gov
Oct 14, 2026 QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals gains Orphan Drug Designation
8-K on SEC.gov
Oct 14, 2026 VSTM Verastem, Inc.
Verastem, Inc. reports strong Q3 revenue and CEO transition
8-K on SEC.gov
Oct 14, 2026 LQDA Liquidia Corp
Liquidia settles with UTC over patent disputes
8-K on SEC.gov
Oct 13, 2026 TRex Bio, Inc.
TREX BIO, INC. files new corporate docs
8-K on SEC.gov
Oct 13, 2026 RVMDW Revolution Medicines, Inc.
Revolution Medicines secures $250M loan
8-K on SEC.gov
Oct 13, 2026 BYSI BeyondSpring Inc.
BeyondSpring Inc. holds 2026 shareholder meeting
8-K on SEC.gov
Oct 13, 2026 BKHAR Black Hawk Acquisition Corp
Black Hawk Acquisition Corp approves business combo
8-K on SEC.gov
Oct 13, 2026 Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals amends corporate docs
8-K on SEC.gov
Oct 13, 2026 SNTI Senti Biosciences Holdings, Inc.
Senti Biosciences adjourns annual meeting
8-K on SEC.gov
Oct 13, 2026 MRK Merck & Co., Inc.
Merck adds Paul Diaz to board
8-K on SEC.gov
Oct 13, 2026 TCRT Alaunos Therapeutics, Inc.
Alaunos Therapeutics acquires Velaris
8-K on SEC.gov
Oct 13, 2026 BIAFW bioAffinity Technologies, Inc.
bioAffinity Technologies announces data presentation
8-K on SEC.gov
Oct 13, 2026 APUS Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals signs BlockAssure deal
8-K on SEC.gov
Oct 13, 2026 OTLC Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics presents at Drug Discovery 2026
8-K on SEC.gov
Oct 13, 2026 PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals completes commercial-scale batch
8-K on SEC.gov
Oct 13, 2026 CRVO CervoMed Inc.
CervoMed Inc. shares trial results
8-K on SEC.gov
Oct 13, 2026 SABSW SAB Biotherapeutics, Inc.
SAB Biotherapeutics gets FDA Fast Track for T1D treatment
8-K on SEC.gov
Oct 13, 2026 MTVA MetaVia Inc.
MetaVia appoints Sarah Browne as CMO
8-K on SEC.gov
Oct 13, 2026 TRAXV First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics updates investor presentation
8-K on SEC.gov
Oct 13, 2026 IBIO iBio, Inc.
iBio reports positive preclinical data for IBIO-610
8-K on SEC.gov
Oct 13, 2026 JNJ JOHNSON & JOHNSON
Johnson & Johnson reports Q3 2026 results
8-K on SEC.gov
Oct 13, 2026 ONCY ONCOLYTICS BIOTECH INC
Oncolytics Biotech extends patent protection to late 2040s
8-K on SEC.gov
Oct 13, 2026 MIRM Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals announces positive Phase 3 trial results
8-K on SEC.gov
Oct 13, 2026 HRMY Harmony Biosciences Holdings, Inc.
Harmony Biosciences CEO to retire in 2026
8-K on SEC.gov
Oct 13, 2026 CDTTW CDT Equity Inc.
CDT Equity Inc. issues $6.75M note
8-K on SEC.gov
Oct 13, 2026 ADIA Adia Med, Inc.
Adia Med repays $934,970 loan
8-K on SEC.gov
Oct 13, 2026 ZTS Zoetis Inc.
Zoetis appoints Iris Knobloch to board
8-K on SEC.gov
Oct 13, 2026 ADCT ADC Therapeutics SA
ADC Therapeutics raises $86.6M via private placement
8-K on SEC.gov
Oct 13, 2026 NRIX Nurix Therapeutics, Inc.
Nurix Therapeutics reports Q3 2026 results
8-K on SEC.gov
Oct 13, 2026 AVBP ArriVent BioPharma, Inc.
ArriVent BioPharma doses first patient in Phase 1 trial
8-K on SEC.gov
Oct 13, 2026 ICCC IMMUCELL CORP /DE/
ImmuCell Corp reports 46% sales increase in Q3 2026
8-K on SEC.gov
Oct 13, 2026 ZBIO Zenas BioPharma, Inc.
Zenas BioPharma announces new obexelimab data.
8-K on SEC.gov
Oct 13, 2026 BBIO BridgeBio Pharma, Inc.
BridgeBio Pharma gets FDA NDA acceptance for infigratinib
8-K on SEC.gov
Oct 9, 2026 SBFMW Sunshine Biopharma Inc.
Sunshine Biopharma Inc. raises $6M
8-K on SEC.gov
Oct 9, 2026 SER Serina Therapeutics, Inc.
Serina Therapeutics eliminates Series A Preferred Stock
8-K on SEC.gov
Oct 9, 2026 MYNZ Quantum Cyber N.V.
Quantum Cyber N.V. launches $100M share offering
8-K on SEC.gov
Oct 9, 2026 ARTL ARTELO BIOSCIENCES, INC.
Artelo Biosciences faces MVLS rule uncertainty
8-K on SEC.gov
Oct 9, 2026 VTGN Vistagen Therapeutics, Inc.
Vistagen amends executive severance plan
8-K on SEC.gov
Oct 9, 2026 MBRX Moleculin Biotech, Inc.
Moleculin Biotech approves stock plan increase
8-K on SEC.gov
Oct 9, 2026 IBO IMPACT BIOMEDICAL INC.
Impact Biomedical Inc. completes reverse stock split
8-K on SEC.gov
Oct 9, 2026 PCVX Vaxcyte, Inc.
Vaxcyte raises $575M via convertible notes
8-K on SEC.gov
Oct 9, 2026 CTRVP Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals acquires GLS
8-K on SEC.gov
Oct 9, 2026 BIAFW bioAffinity Technologies, Inc.
bioAffinity Technologies raises $4M
8-K on SEC.gov
Oct 9, 2026 ISPC iSpecimen Inc.
iSpecimen Inc. holds special meeting
8-K on SEC.gov
Oct 9, 2026 TCRT Alaunos Therapeutics, Inc.
Alaunos Therapeutics faces delisting
8-K on SEC.gov
Oct 9, 2026 MYGN MYRIAD GENETICS INC
Myriad Genetics fires CFO
8-K on SEC.gov
Oct 9, 2026 CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
CTT PHARMACEUTICAL HOLDINGS, INC. files 8-K
8-K on SEC.gov
Oct 9, 2026 CRVO CervoMed Inc.
CervoMed Inc. files Form 8-K
8-K on SEC.gov
Oct 9, 2026 LNAI Lunai Bioworks Inc.
Lunai Bioworks requests stock suspension
8-K on SEC.gov
Oct 9, 2026 VOGX Vogenx, Inc.
Vogenx appoints Richard Gorman as Chief Commercial Officer
8-K on SEC.gov
Oct 9, 2026 EXOZ EXOZYMES INC.
EXOZYMES INC files 8-K
8-K on SEC.gov
Oct 9, 2026 JAZZ Jazz Pharmaceuticals plc
Jazz Pharmaceuticals reports executive retirement
8-K on SEC.gov
Oct 9, 2026 ATOS ATOSSA THERAPEUTICS, INC.
Atossa Therapeutics declares CVR dividend
8-K on SEC.gov
Oct 9, 2026 QNCX Quince Therapeutics, Inc.
Quince Therapeutics names new CEO
8-K on SEC.gov
Oct 8, 2026 XFOR X4 Pharmaceuticals, Inc
X4 Pharmaceuticals secures $150M loan
8-K on SEC.gov
Oct 8, 2026 FBLG FibroBiologics, Inc.
FBLG raises $1.02M via convertible debenture
8-K on SEC.gov
Oct 8, 2026 MDCXW Medicus Pharma Ltd.
Medicus Pharma Ltd. consolidates shares.
8-K on SEC.gov
Oct 8, 2026 SCNX Scienture Holdings, Inc.
Scienture Holdings announces 1-for-25 reverse stock split
8-K on SEC.gov
Oct 8, 2026 CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
CTTH fires auditor
8-K on SEC.gov
Oct 8, 2026 TIVC Valion Bio, Inc.
Valion Bio, Inc. raises $50,000
8-K on SEC.gov
Oct 8, 2026 CATX Perspective Therapeutics, Inc.
Perspective Therapeutics gains FDA Fast Track for PSV359
8-K on SEC.gov
Oct 8, 2026 RNA Atrium Therapeutics, Inc.
Atrium Therapeutics raises $50M
8-K on SEC.gov
Oct 8, 2026 TLRY Tilray Brands, Inc.
Tilray Brands reports record Q1 revenue
8-K on SEC.gov
Oct 8, 2026 EDIT Editas Medicine, Inc.
Editas Medicine gets trial approval for EDIT-401
8-K on SEC.gov
Oct 8, 2026 BIAFW bioAffinity Technologies, Inc.
bioAffinity Technologies gets patent notice
8-K on SEC.gov
Oct 8, 2026 VTRS Viatris Inc
Viatris to Acquire Pacira for $36.50 per Share
8-K on SEC.gov
Oct 8, 2026 VIR Vir Biotechnology, Inc.
Vir Biotechnology gets FDA Fast Track for VIR-5500
8-K on SEC.gov
Oct 8, 2026 PCRX Pacira BioSciences, Inc.
Pacira BioSciences agrees to $36.50 per share acquisition
8-K on SEC.gov